photo walkheader_zpsd5bunpmi.png

Category Archives: Pancreatic Cancer

Better Outcomes in Pancreatic Cancer with Select Treatments for Select Genetic Mutations ?

Some pancreatic cancer patients (hereinafter referring just to those with ductal adenocarcinoma of the pancreas) have substantially better outcomes than the majority. In the paper now reviewed by this blog entry (link at the end of this article) as published in the October 2016 issue of Endocrine-related Cancer journal, the French authors summarize surveillance, prognosis […]

Gemcitabine Confers Comparable FOLFIRINOX Pancreatic Cancer Survival in Those with High hENT1 Levels

The drug gemcitabine is generally well tolerated, but its efficacy for pancreatic cancer (ductal adenocarcinoma of the pancreas) when used as a solitary chemotherapy is now understood to not be as great as that of use in combination with Abraxane, or as that of the four-drug chemotherapy combination regimen – FOLFIRINOX.  However these combination chemotherapy […]

Elements of Protein Breakdown Found in Serum Long Before Pancreatic Cancer Diagnosis

In two separate studies, Boston researchers (primarily) have discovered and begun to characterize the intriguing and likely important finding that protein metabolites found in human serum are elevated typically years before the diagnosis of pancreatic cancer (ductal adenocarcinoma of the pancreas) is established. The implications of this discovery have cast a new light on the early […]

Page 4 of 37« First...23456...102030...Last »
Facebook
Facebook